381
Participants
Start Date
January 22, 2021
Primary Completion Date
August 19, 2024
Study Completion Date
September 12, 2024
AL002
Administered via intravenous (IV) infusion
Placebo
Administered via intravenous (IV) infusion
KaRa Institute of Neurological Disease, Macquarie Park
The Alfred Hospital, Parkville
Box Hill Hospital, Box Hill
Centro de Psiquiatría Biológica Instituto Senecta, Mendoza
SMarT Minds WA, Nedlands
CGM Research Trust, Christchurch
Feinstein Institute For MR, Manhasset
Charité - Universitätsmedizin Berlin (CBF), Berlin
Charite Campus Buch, Berlin
SUNY Upstate Medical Center, Syracuse
Ospedale degli Infermi, Ponderano
University of Rochester Medical Center, Rochester
Abington Neurologic Associates, Abington
Georgetown University Medical Center, Washington D.C.
Fundacion CITA Alzheimer Fundazioa, Donostia / San Sebastian
Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan
Fondazione IRCCS Di Rilievo Nazionale Istituto Nazionale Neurologico Carlo Besta, Milan
ASST degli Spedali Civili di Brescia - Spedali Civili di Brescia, Brescia
IRCCS - Centro S. Giovanni di Dio Fatebenefratelli, Brescia
Hospital Universitario Ramon y Cajal, Madrid
Emory University, Atlanta
Centre Hospitalier Universitaire de Toulouse, Toulouse
Gerontopole, Toulouse
Charter Research, Lady Lake
K2 The Villages, The Villages
ClinCloud, LLC, Maitland
K2 Medical Research, Maitland
Conquest Clinical Research (Winter Park), Winter Park
Brain Matters Research - ERG, Delray Beach
Alzheimers Research and Treatment Center, Wellington
South Florida Neurology Associates, Boca Raton
Axiom Clinical Research FL, Tampa
K2 Winter Garden Ocoee, Ocoee
Hattiesburg Clinic, Hattiesburg
University of Kentucky, Lexington
Ospedale Civile di Baggiovara, Modena
University of Cincinnati MC, Cincinnati
Hospital Universitario Doctor Peset, Valencia
Hospital Universitari i Politecnic La Fe de Valencia, Valencia
Centro de Atencion Especializada Oroitu, Getxo
Hospital Viamed Montecanal, Zaragoza
Azienda Ospedaliero Universitaria Pisana, Pisa
Hôpital Roger Salengro, Lille
AMITA Health Clinical Research Institute, Elk Grove Village
University Clinic Heidelberg, Mannheim
Woodlands Research Network, LLC - ERG, Rogers
Hopital Lariboisiere, Paris
Hôpital de la Pitié Salpétrière, Paris
LMU Klinikum der Universität München, München
Klinikum rechts der Isa der Technischen Universitaet Muenchen, München
Banner Alzheimer's Institute, Phoenix
Universitätsklinikum Ulm, Ulm
ATP Clinical Research, Costa Mesa
Summit Research Network, Portland
Progressive Medical Research, Port Orange
Boston Center for Memory, Newton
Advanced Clinical Institute, Neptune City
Columbia University College of Physicians and Surgeons, New York
Clinical Trial Network, Houston
Instituto Kremer, Córdoba
Okanagan Clinical Trials, Kelowna
True North Clinical Research - Halifax, Halifax
True North Clinical Research - New Minas, New Minas
Parkwood Institute, London
Bruyère Research Institute, Ottawa
Kawartha Regional Memory Clinic, Peterborough
Toronto Memory Clinic, Toronto
Baycrest Health Sciences, Toronto
Fondazione Policlinico Universitario A Gemelli, Rome
Azienda Policlinico Umberto I, Rome
Ospedale S Giovanni Calibita Fatebenefratelli, Rome
Brain Research Center Den Bosch, 's-Hertogenbosch
Brain Research Center Amsterdam, Amsterdam
NZOZ Wroclawskie Centrum Alzheimerowskie, Wroclaw
Centrum Medyczne NeuroProtect, Warsaw
EUROMEDIS Sp. z o.o., Szczecin
SOMED CR, Warsaw
Hospital de La Santa Creu i Sant Pau, Barcelona
Fundacion ACE Instituto Catalan de Neurociencias, Barcelona
Hospital Clinic de Barcelona, Barcelona
Re: Cognition Health - Guildford, Guildford
Re:Cognition Health Bristol, Bristol
Re:Cognition Health London, London
The National Hospital for Neurology and Neurosurgery, London
Greater Manchester Mental Health NHS Foundation Trust, Manchester
Glasgow Memory Clinic, Motherwell
Re:Cognition Health Plymouth, Plymouth
Lead Sponsor
Collaborators (1)
AbbVie
INDUSTRY
Alector Inc.
INDUSTRY